Literature DB >> 7699032

PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.

V A Steingrube1, J L Gibson, B A Brown, Y Zhang, R W Wilson, M Rajagopalan, R J Wallace.   

Abstract

A total of 129 reference and clinical strains of rapidly growing mycobacteria (RGM) belonging to 10 taxonomic groups were studied for restriction fragment length polymorphism patterns from a PCR-amplified 439-bp segment of the 65-kDa heat shock protein (HSP) gene. Of 24 endonucleases evaluated, restriction fragment length polymorphism patterns produced by HaeIII and BstEII and then by AciI and CfoI gave the best separation. Sixty percent of all RGM taxa studied were differentiated by HaeIII digests alone. Single unique patterns were observed with HaeIII and/or BstEII for Mycobacterium fortuitum (100%), M. chelonae (94%), M. abscessus (96%), M. smegmatis (100%), M. mucogenicum (formerly the M. chelonae-like organism) (100%), and the sorbitol-negative third biovariant of M. fortuitum (100%). Evidence is presented in support of two subgroups within M. peregrinum, M. smegmatis, and the unnamed third biovariant of M. fortuitum (sorbitol positive and sorbitol negative). PCR-based technology provides a rapid, accurate system for the identification of clinically important species of RGM which should be particularly useful for reference laboratories.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7699032      PMCID: PMC227898          DOI: 10.1128/jcm.33.1.149-153.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

2.  Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers.

Authors:  G Bolan; A L Reingold; L A Carson; V A Silcox; C L Woodley; P S Hayes; A W Hightower; L McFarland; J W Brown; N J Petersen
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

3.  Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis.

Authors:  B B Plikaytis; B D Plikaytis; M A Yakrus; W R Butler; C L Woodley; V A Silcox; T M Shinnick
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

4.  Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification.

Authors:  P Kirschner; M Kiekenbeck; D Meissner; J Wolters; E C Böttger
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

5.  Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae.

Authors:  L C Steele; R J Wallace
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

6.  Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis.

Authors:  J D Band; J I Ward; D W Fraser; N J Peterson; V A Silcox; R C Good; P R Ostroy; J Kennedy
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

Review 7.  Spectrum of disease due to rapidly growing mycobacteria.

Authors:  R J Wallace; J M Swenson; V A Silcox; R C Good; J A Tschen; M S Stone
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

8.  Identification of clinically significant Mycobacterium fortuitum complex isolates.

Authors:  V A Silcox; R C Good; M M Floyd
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

9.  Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.

Authors:  R J Wallace; B A Brown; V A Silcox; M Tsukamura; D R Nash; L C Steele; V A Steingrube; J Smith; G Sumter; Y S Zhang
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

10.  Human disease due to Mycobacterium smegmatis.

Authors:  R J Wallace; D R Nash; M Tsukamura; Z M Blacklock; V A Silcox
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

View more
  68 in total

1.  Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.

Authors:  G L Woods; J S Bergmann; F G Witebsky; G A Fahle; B Boulet; M Plaunt; B A Brown; R J Wallace; A Wanger
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene.

Authors:  F Brunello; M Ligozzi; E Cristelli; S Bonora; E Tortoli; R Fontana
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Occurrence of nontuberculous mycobacteria in environmental samples.

Authors:  T C Covert; M R Rodgers; A L Reyes; G N Stelma
Journal:  Appl Environ Microbiol       Date:  1999-06       Impact factor: 4.792

4.  Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory.

Authors:  Leslie Hall; Kelly A Doerr; Sherri L Wohlfiel; Glenn D Roberts
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis.

Authors:  R W Wilson; V A Steingrube; B A Brown; Z Blacklock; K C Jost; A McNabb; W D Colby; J R Biehle; J L Gibson; R J Wallace
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 6.  Specificity and performance of PCR detection assays for microbial pathogens.

Authors:  Konrad Sachse
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

7.  Capillary electrophoretic restriction fragment length polymorphism patterns for the Mycobacterial hsp65 gene.

Authors:  Hsin-Tsung Ho; Po-Ling Chang; Chia-Chien Hung; Huan-Tsung Chang
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria.

Authors:  Barbara A Brown-Elliott; Richard J Wallace; Christopher J Crist; Linda Mann; Rebecca W Wilson
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

9.  Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.

Authors:  Richard J Wallace; Barbara A Brown-Elliott; Christopher J Crist; Linda Mann; Rebecca W Wilson
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.

Authors:  Kevin A Nash; Barbara A Brown-Elliott; Richard J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.